NR4A1 and cancer: Finally, there is no evidence in vivo that after surgery, estrogens stimulate the growth of residual cancer cells, and EC metastatic cells have reduced expression of hormone receptors, so it is possible that disease progression depends on alternative oncogenic pathways [76].